During the past decade, NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny" #1 sponsor was "Mannkind Corporation" with 4 trials, followed by "Applied Therapeutics, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Gelesis, Inc." with 1 trials sponsored and "Ionis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Medtronic Poland Spółka z ograniczoną odpowiedzialnością" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny" are "Diabetes Mellitus, Type 1" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Asthma" (1 trials), "Diabetes" (1 trials) and "Diabetes Type 2" (1 trials). Many other conditions were trialed in "NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny" in a lesser frequency.

Most popular intervention types in "NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny" are "Drug" (7 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Technosphere Insulin" (3 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "AT-001" (1 trials) and "Active comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".